SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-039008
Filing Date
2024-03-26
Accepted
2024-03-26 16:03:10
Documents
1
Group Members
JUVVENTURES (UK) LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm249774d1_sc13da.htm SC 13D/A 42924
  Complete submission text file 0001104659-24-039008.txt   44564
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90737 | Film No.: 24783471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB
Business Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB 441624639396
Juvenescence Ltd (Filed by) CIK: 0001724307 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y8 | Fiscal Year End: 1231
Type: SC 13D/A